Z-0216-2024 Class II Ongoing
FDA device recall Z-0216-2024 was initiated by Cepheid on Apr 24, 2023 and is designated Class II. Reason for recall: pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results. The recall status is ongoing. Affected quantity: 1,413 kits ( 10 test per kit).
Recall details
- Product Type
- Devices
- Report Date
- Nov 8, 2023
- Initiation Date
- Apr 24, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,413 kits ( 10 test per kit)
Product description
Xpert Xpress Strep A, REF:Xprstrepa-CE-10, CE IVD,
Reason for recall
pipettes packaged in Strep A test may fail to dispense an adequate sample volume which could result in "invalid" results or no result test results.
Distribution pattern
Worldwide distribution - US Nationwide and the countries of Costa Rica, Ireland, Estonia, United Kingdom, Germany, Italy, Greece, Poland, Switzerland, Hong Kong, United Arab Emirates.
Code information
UDI: (01)07332940006297/ Lot: 23815
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0216-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026